Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide inhaler to prevent chronic lung disease in extremely preterm neonates with RDS
IRCT2015112810430N6Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide in chronic lung disease and respiratory distress syndrome (RDS), sponsored by Isfahan University of Medical Sciences. Started Mar 2015; status: completed.
02
Drugs
budesonide
03
Conditions
chronic lung diseaserespiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT2015112810430N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015112810430N6.